About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT02809339

Improving Quality of Care for Patients With Recurrent Ovarian Cancer

Ovarian cancer is a major cause of cancer related death among women. The disease is usually advanced at diagnosis, because specialist referral is delayed due to vague nature of presenting symptoms. Pr...

Lead sponsor: Radboud University Medical Center•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Mark Rietveld, M.D. Msc.

CONTACT

+31 24 36 10353 mark.rietveld@radboudumc.nl

Sponsors

Lead Sponsor

Radboud University Medical Center

Collaborators

PharmaMar

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Patients with recurrent EOC or tubal carcinoma or peritoneal carcinoma;
•Histologically and/or cytologically proven epithelial ovarian cancer (including carcinosarcoma of the ovaries)
•Measurable or evaluable disease confirmed by radiological imaging OR ca 125
•ECOG ≤2
•Estimated life expectancy ≥12 weeks
•Patients must be accessible for treatment and follow-up
•Fit to receive chemotherapy

Exclusion Criteria

•Patients with benign ovarian cancer;
•Patients with non-epithelial cancer;
•Bowel obstruction, sub-occlusive disease or presence of symptomatic brain metastases;
•Patients with other malignancy occurring within 5 years before enrollment
•Patients with impaired cognitive functioning or analphabetic patients
•Patients with an inability to fill in surveys digitally

Related studies

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

Functional Vision and Quality of Life in a Modern Society - With Emphasis on Myopia and Cerebral Visual Impairment Among Youth

NCT07653074 · Myopia, Quality of Life

Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer

NCT06355050 · Prostate Cancer, Adaptive Radiotherapy, and more

Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients

NCT06141798 · Age Problem, Dialysis; Complications, and more

RECRUITINGPhase 1/2

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

NCT06380816 · Advanced Solid Tumours, Squamous Cell Carcinoma of Head and Neck, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 22, 2016Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment360

Start dateJul 2016

Last updatedJun 22, 2016

Condition

Ovarian Neoplasms Quality of Life

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 22, 2016Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions